pharmacokinetics

(redirected from Therapeutic drug monitoring)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.

pharmacokinetics

[¦fär·mə·kō·ki′ned·iks]
(pharmacology)
The study of the way that drugs move through the body after they are swallowed or injected.
Mentioned in ?
References in periodicals archive ?
For tricyclic antidepressant drugs, for example, such as amitriptyline and desipramine, there is a well-defined relationship between blood concentration and cardiac arrhythmia, and therapeutic drug monitoring is necessary to ensure patient safety.
North America is expected to account for more than half the therapeutic drug monitoring market share in 2015.
Also, under the agreement, MLS will conduct validation studies and market therapeutic drug monitoring tests throughout the US via its specialised sales force.
S curriculum recommended by medical council of India, there is no mention of Therapeutic drug monitoring in practical either of second MBBS or final MBBS.
Title: Competing in the Global Therapeutic Drug Monitoring (TDM) Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts, and Strategic Profiles of Key Players
Despite the lack of clear explanation for the lower etanercept levels in some of the patients in the absence of immunogenicity, this study demonstrates that therapeutic drug monitoring should not be limited only to those agents having a potential to develop anti-drug antibodies.
Details regarding the clinical implications of therapeutic drug monitoring in TB treatment programs remain unclear.
In future studies, we hope to define the role of therapeutic drug monitoring in this situation, and whether treatment with low doses of the SSRI or SNRI would be safe and effective in severe cases.
Details of the research will be presented at the 20th IUBMB International Congress of Biochemistry and Molecular Biology to be held this month and the 23rd Annual Meeting of the Japan Society for Therapeutic Drug Monitoring to be held in July.
THE London-based Delphic Europe, leading UK provider of specialist diagnostics products and services for HIV clinics, has raised pounds 675,000from MMC Ventures and Capital Fund and bought the world-leading clinical therapeutic drug monitoring service developed by the Liverpool HIV Pharmacology Group at Liverpool university.
Debate continues regarding the use of therapeutic drug monitoring, which has since been adopted as standard of care in some European countries, but not in the US.
More than 100 tests are available on the system, including general chemistries, critical care chemistries, proteins, serologies and esoteric chemistries, as well as therapeutic drug monitoring and drugs-of-abuse tests.

Full browser ?